Bio-Path Holdings Reports First Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. TENB
7. BIIB
8. CMG
9. KLAC
10. ETSY

Go back to Bio-Path Holdings Reports First Quarter 2018 Financial Results

Bio-Path Holdings (BPTH) Reports Q1 Loss of $0.17

May 16, 2018 7:08 AM EDT

Bio-Path Holdings (NASDAQ: BPTH) reported Q1 EPS of ($0.17). Revenue for the quarter came in at $0 , versus $0 reported last year.

Throughout the first quarter of 2018, we made major strides advancing our RNAi nanoparticle drugs for the treatment of a variety of cancers with limited treatment options. Specifically, we were delighted to publish and present data in support of our DNAbilize® technology in both peer-viewed journal articles and at key oncology medical meetings. In particular, we were delighted with the interim results from our ongoing Phase 2 clinical trial of prexigebersen for the... More